Oct 26, 2021 / 01:00PM GMT
Operator
Gentlemen, good day, and welcome to the Torrent Pharma Limited Q2 FY '22 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.
Sudhir Menon - Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO
Thank you. Good evening, everyone, and welcome to quarter 2 FY '22 Earnings Call of Torrent Pharma. Quarter 2 was driven by a strong momentum in the branded generic market. In terms of financial performance, during the quarter, the revenues were INR 2,137 crores, up by 6% on Y-o-Y basis. EBITDA was INR 711 crores, up by 11% on Y-o-Y basis. The profit before tax was at INR 472 crores, which was up by 23%. Net profit after taxes were at INR 316 crores, up by 2%.
Aman, over to you for taking us through the India business performance.
Aman Mehta - Torrent Pharmaceuticals Limited - CMO
Thanks, Sudhir. India revenues at INR 1,087 crores grew by 13% on a year-on-year basis.
Q2 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Mar 19, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers